2-chloro-n(6)cyclopentyladenosine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 40 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
---|---|---|---|---|---|
252 | 0 | 43 | 1,333 | 4 | 133 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (57.50) | 18.2507 |
2000's | 11 (27.50) | 29.6817 |
2010's | 5 (12.50) | 24.3611 |
2020's | 1 (2.50) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Conti, A; Ongini, E; Pocar, D; Seminati, M; Viziano, M; Zocchi, C | 1 |
Borea, PA; Camaioni, E; Conti, A; Cristalli, G; Dionisotti, S; Monopoli, A; Ongini, E; Vittori, S; Volpini, R | 1 |
Camaioni, E; Conti, A; Cristalli, G; Dionisotti, S; Monopoli, A; Ongini, E; Vittori, S; Volpini, R; Zocchi, C | 1 |
Fredholm, BB; Hegler, J; Hessling, J; Klotz, KN; Kull, B; Lohse, MJ; Owman, C | 1 |
Cappellacci, L; Franchetti, P; Grifantini, M; Lucacchini, A; Marchetti, S; Martini, C; Mazzoni, MR; Trincavelli, L | 1 |
Barbhaiya, H; IJzerman, AP; Rivkees, SA | 1 |
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T | 1 |
Albinson, FD; Ayres, BE; Butchers, PR; Chambers, CL; Cherry, PC; Ellis, F; Ewan, GB; Gregson, M; Keeling, SE; Knight, J; Mills, K; Ravenscroft, P; Reynolds, LH; Sanjar, S; Sheehan, MJ | 1 |
Jacobson, KA; Ji, X; Li, AH; Marquez, VE; Melman, N; Ravi, RG; Shin, KJ; Siddiqui, MA | 1 |
de Groote, M; IJzerman, AP; Lorenzen, A; Stannek, C; van der Klein, PA; van Tilburg, EW; von Frijtag Drabbe Künzel, J | 1 |
Barak, D; Biadatti, T; Chen, W; Gao, ZG; Jacobson, KA; Johnson, CR; Kim, SG; Kim, SK; Lee, K | 1 |
Beukers, MW; IJzerman, AP; Klaasse, EC; Koomen, GJ; Von Frijtag Drabbe Künzel, JK; Wanner, MJ | 1 |
Deflorian, F; Gao, ZG; Jacobson, KA; Jiang, X; Moss, SM; Paoletta, S; Phan, K; Tosh, DK | 1 |
Dowell, SJ; Frattini, E; Frenguelli, BG; Hemmings, JL; Knight, A; Ladds, G; Leuenberger, M; Lochner, M; Winfield, I | 1 |
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J | 1 |
Auchampach, JA; Bitant, A; Ciancetta, A; Cui, Z; Gao, ZG; Gavrilova, O; Jacobson, KA; Lieberman, DI; Liu, N; Mannes, P; Mattison, JA; Rao, H; Reitman, ML; Rothwell, AC; Salmaso, V; Tosh, DK; Vaughan, KL | 1 |
Angeli, A; Ben, DD; Buccioni, M; Catarzi, D; Ceni, C; Colotta, V; Gratteri, P; Marucci, G; Nocentini, A; Supuran, CT; Varano, F; Volpini, R | 1 |
Lucchi, R; Poli, A; Rosati, AM; Traversa, U | 1 |
Bonizzoni, E; Casati, C; Milani, S; Monopoli, A; Ongini, E | 1 |
Schiele, JO; Schwabe, U | 1 |
Christofi, FL; Wood, JD | 1 |
Chintala, M; Chiu, PJ; Dionisotti, S; Ongini, E; Sandoli, D | 1 |
Conti, A; Dionisotti, S; Gatta, F; Ongini, E; Sandoli, D; Zocchi, C | 1 |
Bonizzoni, E; Casati, C; Dionisotti, S; Monopoli, A; Ongini, E; Zocchi, C | 1 |
Bottrill, FE; Hiley, CR; Richardson, PJ; Warnock, J | 1 |
Adami, M; Bertorelli, R; Ferri, N; Foddi, MC; Ongini, E | 1 |
Busca, G; Castoldi, G; Genovesi, S; Golin, R; Panzacchi, G; Protasoni, G; Stella, A | 1 |
De Sarro, A; De Sarro, G; Donato Di Paola, E; Falconi, U; Ferreri, G | 1 |
Florio, C; Rosati, AM; Traversa, U; Vertua, R | 1 |
Casati, C; Forlani, A; Lozza, G; Monopoli, A | 1 |
Busca, G; Demarchi, B; Golin, R; Panzacchi, G; Protasoni, G; Stella, A | 1 |
Cutler, BS; Dobson, JG; Fenton, RA; Li, Jm; Peyton, BD; Powell, CC; Wheeler, HB | 1 |
Camisasca, P; Genovesi, S; Golin, R; Pieruzzi, F; Protasoni, G; Ragonesi, G; Stella, A; Zanchetti, A | 1 |
Doering, A; Middlekauff, HR; Weiss, JN | 1 |
Belem, PC; Chen, JF; Cronstein, B; Elson, G; Fink, JS; Jacobson, M; Leibovich, SJ; Montesinos, C; Pinhal-Enfield, G; Ramanathan, M; Rosania, A; Schwarzschild, MA | 1 |
Aqvist, J; Centeno, NB; Gutiérrez-de-Terán, H; Pastor, M; Sanz, F | 1 |
Mustafa, SJ; Oldenburg, PJ; Schnermann, J; Tawfik, HE | 1 |
Cao, Y; Xie, KQ; Zhu, XZ | 1 |
Mustafa, SJ; Nadeem, A; Ponnoth, DS; Tilley, S | 1 |
1 review(s) available for 2-chloro-n(6)cyclopentyladenosine and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
39 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity.
Topics: Adenosine; Animals; Aorta; Hydrazines; In Vitro Techniques; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Structure-Activity Relationship; Vasodilator Agents | 1995 |
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Male; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1 | 1995 |
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Chemical Phenomena; Chemistry, Physical; Heart Rate; Hydroxylation; Male; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Structure-Activity Relationship; Vasodilation | 1994 |
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Base Composition; Binding, Competitive; CHO Cells; Cricetinae; Guanylate Cyclase; Humans; Phenethylamines; Phenylisopropyladenosine; Receptors, Purinergic P1; Stereoisomerism; Structure-Activity Relationship; Transfection; Xanthines | 1998 |
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Brain; Cattle; Enzyme Inhibitors; In Vitro Techniques; Male; Membranes; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Testis | 1998 |
Identification of the adenine binding site of the human A1 adenosine receptor.
Topics: Adenine; Amides; Amino Acid Sequence; Amino Acids; Binding Sites; DNA, Complementary; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Receptors, Purinergic P1 | 1999 |
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines | 1999 |
The discovery and synthesis of highly potent, A2a receptor agonists.
Topics: Adenosine; Anti-Inflammatory Agents; GTP-Binding Proteins; Purinergic P1 Receptor Agonists; Solubility; Structure-Activity Relationship | 2000 |
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
Topics: Animals; Cell Membrane; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Purine Nucleosides; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Sulfur Radioisotopes | 2000 |
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
Topics: Adenosine; Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Cricetinae; Cyclic AMP; Humans; In Vitro Techniques; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Structure-Activity Relationship | 2001 |
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Epoxy Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Models, Molecular; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ribose; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship | 2002 |
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
Topics: Adenosine; Animals; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Agonists; Radioligand Assay; Structure-Activity Relationship; Triazenes | 2003 |
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
Topics: Animals; Anticonvulsants; CHO Cells; Cricetinae; Cricetulus; Humans; Male; Mice; Molecular Docking Simulation; Nucleosides; Protein Conformation; Receptor, Adenosine A1; Structure-Activity Relationship | 2012 |
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
Topics: Adenosine; Bridged Bicyclo Compounds, Heterocyclic; Cyclopentanes; Dose-Response Relationship, Drug; Drug Discovery; Humans; Molecular Structure; Purinergic P1 Receptor Agonists; Receptor, Adenosine A1; Receptor, Adenosine A3; Structure-Activity Relationship; Substrate Specificity | 2016 |
Polypharmacology of N
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3 | 2017 |
Design and in Vivo Characterization of A
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Bridged Bicyclo Compounds; CHO Cells; Cricetulus; Drug Design; HEK293 Cells; Humans; Macaca fascicularis; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Receptor, Adenosine A1; Structure-Activity Relationship | 2019 |
Discovery of first-in-class multi-target adenosine A
Topics: Adenosine A2 Receptor Antagonists; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; CHO Cells; Cricetulus; Enzyme Assays; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrazines; Receptor, Adenosine A2A; Structure-Activity Relationship; Triazoles | 2020 |
Biochemical and pharmacological evidence for the presence of A1 but not A2a adenosine receptors in the brain of the low vertebrate teleost Carassius auratus (goldfish).
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Goldfish; Hydrogen-Ion Concentration; Mammals; Neurotransmitter Agents; Phenethylamines; Radioligand Assay; Receptors, Purinergic P1; Species Specificity; Temperature | 1995 |
Modeling hemodynamic profiles by telemetry in the rat. A study with A1 and A2a adenosine agonists.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic alpha-Agonists; Animals; Hemodynamics; Male; Models, Biological; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Telemetry | 1995 |
Characterization of the adenosine receptor in microvascular coronary endothelial cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Antihypertensive Agents; Cells, Cultured; Colforsin; Coronary Vessels; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Guinea Pigs; Isoproterenol; Myocardium; Phenethylamines; Phenylisopropyladenosine; Receptors, Purinergic P1; Thioinosine; Vasodilator Agents | 1994 |
Electrophysiological subtypes of inhibitory P1 purinoceptors on myenteric neurones of guinea-pig small bowel.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Membrane Potentials; Myenteric Plexus; Phenethylamines; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1 | 1994 |
In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbit.
Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Rabbits | 1994 |
Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphoric Diester Hydrolases; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles; Vasodilator Agents; Xanthines | 1994 |
Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Drug Tolerance; Hemodynamics; Male; Phenethylamines; Rats; Rats, Inbred SHR; Receptors, Purinergic P1 | 1994 |
Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antihypertensive Agents; Carbachol; Colforsin; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; Nitroprusside; Perfusion; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Xanthines | 1995 |
Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticonvulsants; Dose-Response Relationship, Drug; Male; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Seizures | 1995 |
Effects of adenosine-receptor agonists on renin release in anaesthetized rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Hemodynamics; Infusions, Intravenous; Kidney; Nerve Fibers; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Renin | 1995 |
Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
Topics: Acoustic Stimulation; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticonvulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Mice; Mice, Inbred DBA; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Triazoles; Xanthines | 1996 |
Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antineoplastic Agents; Male; Mice; Motor Activity; Purinergic P1 Receptor Agonists; Purines; Sulfonamides; Theophylline; Xanthines | 1997 |
Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents | 1997 |
Effects of adenosine receptor agonists on renal function in anaesthetized rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Pressure; Denervation; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Male; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Purinergic P1; Receptors, Purinergic P2; Sodium; Urodynamics | 1997 |
Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carotid Arteries; Cells, Cultured; Endothelium, Vascular; Humans; Iliac Artery; Nitric Oxide; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Swine; Triazines; Triazoles; Xanthines | 1998 |
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Baroreflex; Blood Pressure; Denervation; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Kidney; Male; Neurons, Efferent; Nitroprusside; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Regression Analysis; Sympathetic Nervous System; Time Factors; Vagotomy | 2000 |
Adenosine enhances neuroexcitability by inhibiting a slow postspike afterhyperpolarization in rabbit vagal afferent neurons.
Topics: Action Potentials; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cadmium; Colforsin; Neurons, Afferent; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rabbits; Receptors, Purinergic P1; Time Factors; Vagus Nerve; Xanthines | 2001 |
Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blotting, Western; Cells, Cultured; Drosophila Proteins; Endothelial Growth Factors; Female; Interferon-gamma; Lipopolysaccharides; Lymphokines; Macrophages, Peritoneal; Male; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenethylamines; Protein Kinase Inhibitors; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Cell Surface; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Theobromine; Toll-Like Receptor 4; Toll-Like Receptors; Triazines; Triazoles; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xanthines | 2002 |
Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Binding Sites; Humans; Mathematics; Models, Molecular; Receptor, Adenosine A1; Thermodynamics | 2004 |
Role of A1 adenosine receptors in regulation of vascular tone.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Aorta; Female; In Vitro Techniques; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Receptor, Adenosine A1; Type C Phospholipases; Vasodilation; Vasodilator Agents; Xanthines | 2005 |
Role of the second transmembrane domain of rat adenosine A1 receptor in ligand-receptor interaction.
Topics: Adenine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Amino Acid Sequence; Animals; Cell Line; Cell Membrane; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Protein Structure, Tertiary; Rats; Receptor, Adenosine A1; Xanthines | 2006 |
Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Inhalation; Aerosols; Ambrosia; Animals; Antigens, Plant; Aorta; Asthma; Blotting, Western; Bronchial Hyperreactivity; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Plethysmography, Whole Body; Polymerase Chain Reaction; Receptor, Adenosine A1; RNA, Messenger; Vasodilation | 2010 |